Patent Assignment
Reel/Frame 030719/0474
Change of Name
Recorded: 2013-07-01
Pages: 4
Assignor
BAYER PHARMA AKTIENGESELLSCHAFT
Executed: 2012-04-01
Assignee
BAYER INTELLECTUAL PROPERTY GMBH
CREATIVE CAMPUS MONHEIM, BUILDING 4865, ALFRED-NOBEL-STRABE 10, MONHEIM, 40789, GERMANY
Covered Properties
(17)
Polymer-Bonded Complexing Agents and Pharmaceutical Agents Containing Them for MR1
Patent:
5,681,543 →
Application:
08/289,341 →
Derivatized Dtpa Complexes, Pharmaceutical Agents Containing These Compounds, Their Use, and Processes for Their Production
Patent:
5,695,739 →
Application:
08/351,126 →
9-Alpha-Substituted Estratrienes as Selectively Active Estrogens
Uv Stable Transdermal Therapeutic Plaster with a Uv Absorbing Adhesive Layer Separated from the Drug Matrix
Vegfr-2 and Vegfr-3 Inhibitory Anthranilamide Pyridines
Sulfoximine-Substituted Pyrimidines as Cdk-and/or Vegf Inhibitors, Their Production and Use as Pharmaceutical Agents
Management of Breakthrough Bleeding in Extended Hormonal Contraceptive Regimens
Novel Nicotinamide Pyridinureas as Vascular Endothelial Growth Factor (Vegf) Receptor Kinase Inhibitors
Substituted Arylpyrazolopyridines and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Substituted Aminopyrazolopyridines and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Use of Estradiol Valerate or 17BETA-Estradiol in Combination with Dienogest for Oral Therapy to Maintain and/or Increase Feminine Libido
Metal Chelates Having a Perfluorinated Peg Radical, Processes for Their Preparation, and Their Use
Process for the Preparation of 17-(3-Hydroxypropyl)-17-Hydroxysteroids
Process for Preparing Epothilone Derivatives by Selective Catalytic Epoxidation
17-Hydroxy-17-Pentafluoroethyl-Estra-4,9(10)-Dien-11-Aryl Derivatives, Method of Production Thereof and Use Thereof for the Treatment of Diseases
Hormone Replacement Therapy and Depression
Application:
13/411,131 →
Publication:
US 2012/0225853
Management of Breakthrough Bleeding in Extended Hormonal Contraceptive Regimens
Application:
13/448,585 →
Publication:
US 2012/0202779
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Nov 11, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029277/0286 →
Change of Name
Nov 14, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 029293/0348 →
Assignment of Assignor's Interest
Nov 22, 2019
From: BAYER INTELLECTUAL PROPERTY GMBH
To: LUYE PHARMA SWITZERLAND AG
Reel/Frame 051088/0904 →
Change of Address
Jun 12, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 064021/0344 →